◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Medexus Pharmaceuticals Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Total Revenue 108.3M 113.1M 108.1M 76.7M --
Operating Revenue 108.3M 113.1M 108.1M 76.7M --
Cost Of Revenue 51.7M 53.5M 48.1M 38.8M --
Gross Profit 56.6M 59.5M 60.0M 37.9M --
Selling General And Administration 36.1M 38.4M 42.2M 38.6M --
General And Administrative Expense 28.3M 27.9M 30.8M 29.1M --
Research And Development 8.3M 8.0M 9.0M 11.3M --
Depreciation And Amortization In Income Statement 253,000 251,000 353,000 398,000 --
Operating Expense 44.7M 46.7M 51.5M 50.3M --
Operating Income 11.9M 12.8M 8.5M -12.4M --
EBIT 9.6M 13.5M 8.6M 8.4M --
Interest Expense 8.2M 13.4M 13.6M 12.2M --
Interest Expense Non Operating 8.2M 13.4M 13.6M 12.2M --
Interest Income -- -- -- -- 3,000
Interest Income Non Operating -- -- -- -- 3,000
Net Interest Income -8.2M -13.4M -13.6M -12.2M --
Other Income Expense -2.3M 683,000 76,000 20.8M --
Special Income Charges -1.2M 766,000 -768,000 -164,000 --
Restructuring And Mergern Acquisition -1.6M -1.7M 768,000 -1.6M --
Gain On Sale Of Security -1.1M -83,000 844,000 20.9M --
Pretax Income 1.4M 106,000 -5.0M -3.8M --
Tax Provision -807,000 320,000 -6.3M -941,000 --
Tax Effect Of Unusual Items -342,900 102,450 30,400 5.1M --
Net Income From Continuing And Discontinued Operation 2.2M -214,000 1.2M -2.9M --
Net Income From Continuing Operation Net Minority Interest 2.2M -214,000 1.2M -2.9M --
Net Income Including Noncontrolling Interests 2.2M -214,000 1.2M -2.9M --
Net Income Common Stockholders 2.2M -214,000 1.2M -2.9M --
Net Income 2.2M -214,000 1.2M -2.9M --
EBITDA 16.8M 19.3M 14.6M 14.5M --
Normalized EBITDA 19.1M 18.6M 14.6M -6.2M --
Reconciled Depreciation 7.2M 5.8M 6.1M 6.1M --
Basic EPS 0.09 -0.01 0.06 -0.15 --
Diluted EPS 0.08 -0.01 0.06 -0.15 --
Basic Average Shares 25.8M 22.3M 20.0M 19.5M --
Diluted Average Shares 26.5M 22.3M 20.5M 19.9M --
Total Unusual Items -2.3M 683,000 76,000 20.8M --
Total Unusual Items Excluding Goodwill -2.3M 683,000 76,000 20.8M --
Tax Rate For Calcs 0.15 0.15 0.40 0.25 --
Normalized Income 4.2M -794,550 1.2M -18.5M --
Depreciation Amortization Depletion Income Statement 253,000 251,000 353,000 398,000 --
Depreciation Income Statement 253,000 251,000 353,000 398,000 --
Diluted NI Availto Com Stockholders 2.2M -214,000 1.2M -2.9M --
Impairment Of Capital Assets 2.8M 888,000 0.00 1.8M --
Net Income Continuous Operations 2.2M -214,000 1.2M -2.9M --
Net Non Operating Interest Income Expense -8.2M -13.4M -13.6M -12.2M --
Other Gand A 6.2M 5.7M 6.8M 7.9M --
Reconciled Cost Of Revenue 44.8M 48.0M 42.3M 33.0M --
Salaries And Wages 22.2M 22.1M 24.0M 21.2M --
Selling And Marketing Expense 7.8M 10.6M 11.4M 9.5M --
Total Expenses 96.4M 100.3M 99.6M 89.1M --
Total Operating Income As Reported 8.2M 10.8M 7.6M -15.0M --
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Cash And Cash Equivalents 24.0M 5.3M 13.1M 10.0M --
Cash Cash Equivalents And Short Term Investments 24.0M 5.3M 13.1M 10.0M --
Accounts Receivable 13.2M 23.9M 22.0M 13.4M --
Receivables 13.3M 24.0M 22.4M 14.4M --
Inventory 35.3M 30.8M 22.8M 21.4M --
Prepaid Assets 7.6M 10.1M 12.4M 2.1M --
Other Current Assets 376,000 2.3M 2.3M 1.3M --
Current Assets 80.6M 72.5M 73.0M 49.1M --
Gross PPE 2.0M 1.9M 1.8M 2.1M --
Accumulated Depreciation -1.4M -1.1M -874,000 -868,000 --
Net PPE 689,000 778,000 899,000 1.2M --
Goodwill 10.0M 10.3M 10.3M 10.7M --
Goodwill And Other Intangible Assets 81.6M 74.4M 80.7M 87.3M --
Other Intangible Assets 71.6M 64.1M 70.4M 76.6M --
Other Non Current Assets -- -- -- 1.6M 2.1M
Total Non Current Assets 91.3M 83.2M 88.4M 90.1M --
Total Assets 171.8M 155.7M 161.3M 139.2M --
Current Debt 37.0M 15.7M 42.7M 15.0M --
Current Debt And Capital Lease Obligation 37.0M 15.7M 42.7M 15.0M --
Accounts Payable 5.7M 7.8M 10.2M 12.0M --
Payables 30.5M 18.3M 14.8M 13.3M --
Payables And Accrued Expenses 60.2M 47.8M 38.1M 30.4M --
Current Accrued Expenses 29.7M 29.4M 23.3M 17.1M --
Other Current Liabilities 125,000 2.7M 2.7M 2.6M --
Current Liabilities 97.3M 66.2M 83.5M 48.1M --
Long Term Debt 198,000 34.2M 27.4M 39.8M --
Long Term Debt And Capital Lease Obligation 198,000 34.2M 27.4M 39.8M --
Total Non Current Liabilities Net Minority Interest 22.4M 59.2M 55.4M 73.3M --
Total Liabilities Net Minority Interest 119.7M 125.4M 138.9M 121.4M --
Common Stock 96.1M 76.4M 69.0M 68.7M --
Capital Stock 96.1M 76.4M 69.0M 68.7M --
Additional Paid In Capital 12.0M 12.0M 11.3M 10.4M --
Retained Earnings -62.0M -64.2M -64.0M -65.2M --
Gains Losses Not Affecting Retained Earnings 6.0M 6.2M 6.2M 4.0M --
Common Stock Equity 52.1M 30.3M 22.4M 17.8M --
Stockholders Equity 52.1M 30.3M 22.4M 17.8M --
Total Equity Gross Minority Interest 52.1M 30.3M 22.4M 17.8M --
Total Capitalization 52.3M 64.5M 49.8M 57.6M --
Net Tangible Assets -29.5M -44.1M -58.2M -69.5M --
Tangible Book Value -29.5M -44.1M -58.2M -69.5M --
Working Capital -16.7M 6.3M -10.5M 1.0M --
Invested Capital 89.3M 80.2M 92.5M 72.7M --
Total Debt 37.2M 49.9M 70.1M 54.9M --
Net Debt 13.2M 44.6M 57.0M 44.8M --
Share Issued 32.3M 24.5M 20.2M 20.0M --
Ordinary Shares Number 32.3M 24.5M 20.2M 20.0M --
Allowance For Doubtful Accounts Receivable -801,000 0.00 -- -- --
Buildings And Improvements 781,000 780,000 700,000 1.0M --
Derivative Product Liabilities -- -- 0.00 2.7M 23.7M
Finished Goods 14.8M 17.5M 14.9M 13.6M --
Foreign Currency Translation Adjustments 6.0M 6.2M 6.2M 4.0M --
Gross Accounts Receivable 14.0M 23.9M -- -- --
Income Tax Payable 1.4M 1.3M 1.2M 27,000 --
Interest Payable -- -- -- -- 102,000
Machinery Furniture Equipment 1.3M 1.1M 1.1M 1.1M --
Non Current Deferred Assets 9.0M 8.0M 6.8M 0.00 --
Non Current Deferred Liabilities -- -- 0.00 1.5M 2.6M
Non Current Deferred Taxes Assets 9.0M 8.0M 6.8M 0.00 --
Non Current Deferred Taxes Liabilities -- -- 0.00 1.5M 2.6M
Other Current Borrowings 37.0M 15.7M 42.7M 15.0M --
Other Payable 23.4M 9.3M 3.5M 1.2M --
Other Properties -- 780,000 700,000 1.0M 908,000
Other Receivables -- -- -- 705,000 145,000
Properties 0.00 0.00 0.00 0.00 --
Raw Materials 1.5M 1.1M 1.7M 2.3M --
Taxes Receivable 136,000 161,000 410,000 311,000 --
Total Tax Payable 1.4M 1.3M 1.2M 27,000 --
Tradeand Other Payables Non Current 22.2M 25.0M 28.0M 29.3M --
Work In Process 19.0M 12.2M 6.3M 5.5M --
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Operating Cash Flow 24.0M 18.7M -1.4M -1.2M --
Cash Flow From Continuing Operating Activities 24.0M 18.7M -1.4M -1.2M --
Depreciation And Amortization 7.2M 5.8M 6.1M 6.1M --
Depreciation Amortization Depletion 7.2M 5.8M 6.1M 6.1M --
Stock Based Compensation 411,000 469,000 1.2M 1.9M --
Deferred Tax -807,000 320,000 -6.3M -941,000 --
Deferred Income Tax -807,000 320,000 -6.3M -941,000 --
Change In Working Capital 5.8M 2.3M -15.3M 4.7M --
Changes In Account Receivables 10.5M -1.7M -8.2M 4.4M --
Change In Receivables 10.5M -1.7M -8.2M 4.4M --
Change In Inventory -4.6M -6.8M -2.0M -6.7M --
Change In Payables And Accrued Expense -2.0M 8.6M 4.8M 3.6M --
Change In Other Working Capital -- -- 1,000 -- --
Change In Other Current Assets 1.9M -24,000 563,000 700,000 --
Change In Other Current Liabilities -2.5M 0.00 -- -- --
Other Non Cash Items 5.7M 10.6M 13.5M 12.2M --
Capital Expenditure -2.7M -266,000 -362,000 -7.7M --
Purchase Of PPE -183,000 -50,000 -61,000 -97,000 --
Net PPE Purchase And Sale -183,000 -50,000 -61,000 -97,000 --
Purchase Of Business -3.3M -3.2M -1.4M -482,000 --
Investing Cash Flow -6.0M -3.5M -1.7M -8.2M --
Cash Flow From Continuing Investing Activities -6.0M -3.5M -1.7M -8.2M --
Issuance Of Debt 0.00 17.6M 35.5M 3.9M --
Repayment Of Debt -14.2M -44.0M -24.7M -164,000 --
Net Issuance Payments Of Debt -14.2M -26.4M 10.7M 3.7M --
Issuance Of Capital Stock 19.2M 7.6M 0.00 0.00 --
Net Common Stock Issuance 19.2M 7.6M 0.00 0.00 --
Financing Cash Flow 796,000 -23.0M 6.4M 663,000 --
Cash Flow From Continuing Financing Activities 796,000 -23.0M 6.4M 663,000 --
Effect Of Exchange Rate Changes -111,000 -2,000 -189,000 27,000 --
Changes In Cash 18.8M -7.8M 3.2M -8.7M --
Beginning Cash Position 5.3M 13.1M 10.0M 18.7M --
End Cash Position 24.0M 5.3M 13.1M 10.0M --
Free Cash Flow 21.3M 18.4M -1.8M -8.9M --
Amortization Cash Flow 6.9M 5.6M 5.7M 5.7M --
Amortization Of Intangibles 6.9M 5.6M 5.7M 5.7M --
Asset Impairment Charge 2.8M 888,000 0.00 1.8M --
Cash Dividends Paid 0.00 0.00 0.00 0.00 --
Change In Prepaid Assets 2.5M 2.2M -10.4M 2.7M --
Common Stock Issuance 19.2M 7.6M 0.00 0.00 --
Depreciation 253,000 251,000 353,000 398,000 --
Earnings Losses From Equity Investments -- -- -107,000 -2.5M 1.7M
Gain Loss On Investment Securities -- -82,000 -2.5M -21.1M 20.6M
Interest Paid Cff -4.3M -4.2M -4.3M -3.1M --
Interest Received Cfi -- -- -- -- 3,000
Long Term Debt Issuance 0.00 17.6M 35.5M 3.9M --
Long Term Debt Payments -14.2M -5.0M -24.7M -164,000 --
Net Business Purchase And Sale -3.3M -3.2M -1.4M -482,000 --
Net Foreign Currency Exchange Gain Loss 870,000 1,000 1.5M 146,000 --
Net Income From Continuing Operations 2.2M -214,000 1.2M -2.9M --
Net Intangibles Purchase And Sale -2.5M -216,000 -301,000 -7.6M --
Net Long Term Debt Issuance -14.2M 12.6M 10.7M 3.7M --
Net Other Financing Charges -- -- -- -- -297,000
Net Short Term Debt Issuance 0.00 -39.0M 0.00 -- --
Operating Gains Losses 870,000 -81,000 -1.0M -23.4M --
Proceeds From Stock Option Exercised 140,000 0.00 -- -- --
Purchase Of Intangibles -2.5M -216,000 -301,000 -7.6M --
Short Term Debt Payments 0.00 -39.0M 0.00 -- --
Taxes Refund Paid -224,000 -1.4M -910,000 -684,000 --
NEWS
Loading news...
TRENDING
Loading...